UNITY BIOTECHNOLOGY INC - COM (UBX)

CUSIP: 91381U101

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM
Total 13F shares
21,899,578
Share change
+98,250
Total reported value
$127,018,984
Price per share
$5.80
Number of holders
71
Value change
-$73,090
Number of buys
29
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 91381U101?
CUSIP 91381U101 identifies UBX - UNITY BIOTECHNOLOGY INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITY BIOTECHNOLOGY INC - COM (UBX) as of Q1 2020

As of 31 Mar 2020, UNITY BIOTECHNOLOGY INC - COM (UBX) was held by 71 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,899,578 shares. The largest 10 holders included FMR LLC, BAILLIE GIFFORD & CO, BlackRock Inc., Invus Financial Advisors, LLC, Capital World Investors, Mayo Clinic, VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP. This page lists 71 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.